Last Update 22 Jun 26
4401: Share Buybacks And Dividend Increase Will Support Long Term Prospects
Analysts have kept their price target for Adeka unchanged at ¥4,648, citing slightly adjusted assumptions around the discount rate, revenue growth, profit margins and future P/E as they refine their valuation framework.
What's in the News for Adeka
- A board meeting is scheduled for June 19, 2026 to consider disposal of treasury shares as restricted stock compensation, according to company disclosures.
- There is an update on the share buyback program, with 882,100 shares repurchased from April 1, 2026 to May 29, 2026 for ¥3,502.67 million, completing a total of 4,823,900 shares repurchased for ¥17,999.94 million under the program announced on August 8, 2025.
- A board meeting on May 14, 2026 will consider changes in the representative director and officers, along with a notice regarding distribution of dividends from surplus that includes a dividend increase.
- An earlier buyback tranche update reported 1,093,200 shares repurchased from January 1, 2026 to March 31, 2026 for ¥4,772.37 million, bringing total repurchases under the same program to 3,941,800 shares for ¥14,497.27 million.
Valuation Changes
- Fair Value: Unchanged at ¥4,648, with no adjustment made to the central valuation estimate for Adeka.
- Discount Rate: Risen slightly from 5.28% to 5.29%, reflecting a modestly higher required return in the updated model.
- Revenue Growth: Reduced from 5.53% to 5.15%, indicating slightly more conservative expectations for Adeka's future top line expansion.
- Net Profit Margin: Trimmed from 7.03% to 6.96%, pointing to a small downward adjustment in projected profitability.
- Future P/E: Adjusted marginally lower from 14.03x to 13.99x, signaling a slightly more restrained multiple applied to Adeka's earnings outlook.
Key Takeaways
- Restructuring into Electronics and Environmental Materials divisions aims to boost future revenue and margins through efficiency and collaboration.
- Expanding international markets and strategic focus on high-demand sectors could drive significant revenue growth and enhance shareholder value.
- Challenges in Life Science and Electronics segments, along with market volatility, could significantly impact operating profits, revenue growth, and overall earnings stability.
Catalysts
About Adeka- Engages in chemicals, food products, and life science businesses.
- ADEKA is expecting a gradual recovery in demand for semiconductors in the second and third quarters, driven by robust investments in AI-related fields and a partial recovery in semiconductor demand. This is likely to contribute to increased sales in advanced semiconductor materials, positively impacting revenue and operating profit.
- The restructuring of ADEKA's Chemicals segment into Electronics and Environmental Materials divisions, focusing on semiconductors and eco-friendly products, reflects proactive investment in new materials and semiconductor peripherals. This organizational change aims to enhance efficiency and collaboration, potentially driving future revenue growth and improving margins.
- ADEKA's strategic focus on expanding sales channels for semiconductor materials and battery materials commercialization indicates potential growth in these high-demand sectors. This initiative is anticipated to drive increased revenue and operating profit over the long term.
- The divestment of Treasury Shares and ADEKA's continued inclusion in indices like the JPX-Nikkei Index 400 suggests improved shareholder value propositions, which could support share price appreciation and enhance earnings per share (EPS) through enhanced investor confidence.
- With an overseas sales ratio on an upward trend, now at 55.3%, ADEKA’s expansion into international markets could drive significant revenue growth. The midterm management plan, targeting improvements in operating profit and return on equity, emphasizes commitment to achieving financial growth and stability.
Adeka Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Adeka's revenue will grow by 5.2% annually over the next 3 years.
- Analysts assume that profit margins will increase from 6.7% today to 7.0% in 3 years time.
- Analysts expect earnings to reach ¥33.7 billion (and earnings per share of ¥346.23) by about June 2029, up from ¥27.9 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as ¥37.3 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 14.0x on those 2029 earnings, down from 15.2x today. This future PE is greater than the current PE for the JP Chemicals industry at 13.6x.
- Analysts expect the number of shares outstanding to decline by 3.81% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 5.29%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- The increase in fixed costs and inventory adjustments, particularly in segments like Life Science, could weigh heavily on operating profit, impacting earnings.
- Weak sales in the Life Science segment, driven by inventory issues and weak demand in key markets such as India and North America, pose a risk to revenue growth.
- The high degree of volatility in foreign exchange markets contributes to uncertainty in financial forecasts, potentially affecting net margins and revenue.
- Falling prices in competitive markets like Brazil for agrochemicals and commodity materials might pressure profit margins and lead to earnings volatility.
- Continued weakness in demand for certain semiconductor and display materials could limit growth potential in the Electronics and IT Materials segment, impacting overall revenue and earnings.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of ¥4648.33 for Adeka based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ¥5490.0, and the most bearish reporting a price target of just ¥3200.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be ¥484.3 billion, earnings will come to ¥33.7 billion, and it would be trading on a PE ratio of 14.0x, assuming you use a discount rate of 5.3%.
- Given the current share price of ¥4373.0, the analyst price target of ¥4648.33 is 5.9% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Adeka?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.